Core Laboratories (CLB) Tops Q3 EPS by 1c

Core Laboratories (NYSE: CLB) reported Q3 EPS of $0.64, $0.01 better than the analyst estimate of $0.63. Revenue for the quarter came in at $182.1 million versus the consensus estimate of $178.48 million.

GUIDANCE:

Core Laboratories sees Q4 2018 EPS of $0.48-$0.54, versus the consensus of $0.58. Core Laboratories sees Q4 2018 revenue of $173-176 million, versus the consensus of $175.8 million.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.

You May Also Be Interested In

• Helen of Troy (HELE) Tops Q1 EPS by 22c, Beats on Revenue; Offers FY Guidance
• Eli Lilly (LLY) PT Raised to $1,370 at Truist Securities
• Samsung 2q Oper Profit 89.40t Won, Est. 84.2t Won